4-[6-(2-Aminoethyl)naphthalen-2-yl]benzonitriles are potent histamine H3 receptor antagonists with high CNS penetration

被引:18
作者
Black, Lawrence A. [1 ]
Nersesian, Diana L.
Sharma, Padam
Ku, Yi-Yin
Bennani, Youssef L.
Marsh, Kennan C.
Miller, Thomas R.
Esbenshade, Timothy A.
Hancock, Arthur A.
Cowart, Marion
机构
[1] Abbott Labs, GPRD, Neurosci Res, Abbott Pk, IL 60064 USA
[2] Abbott Labs, GPRD, Proc Res, Abbott Pk, IL 60064 USA
[3] Abbott Labs, GPRD, Exploratory Sci, Abbott Pk, IL 60064 USA
关键词
histamine H3 receptor antagonists; naphthalene; high CNS penetration;
D O I
10.1016/j.bmcl.2006.11.073
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
4-[6-(2-Tertiaryaminoethyl)naphthalen-2-yl]benzonitriles are conformationally constrained histamine H-3 receptor antagonists with high potency and selectivity. The analogs were designed around a naphthalene core, with the goal of enhancing lipophilicity and CNS penetration, as compared to a previously reported benzofuran series. The SAR of the tertiary amine moiety is similar to that reported for the benzofuran series, with analogs bearing a 2-methylpyrrolidine substituent possessing the greatest rat and human H-3 receptor binding affinities. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1443 / 1446
页数:4
相关论文
共 37 条
  • [1] Andrés JM, 2000, EUR J ORG CHEM, V2000, P1719
  • [2] A new class of diamine-based human histamine H3 receptor antagonists:: 4-(aminoalkoxy)benzylamines
    Apodaca, R
    Dvorak, CA
    Xiao, W
    Barbier, AJ
    Boggs, JD
    Wilson, SJ
    Lovenberg, TW
    Carruthers, NI
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (18) : 3938 - 3944
  • [3] Apodaca R., 2003, PCT Int. Appl., WO, Patent No. 2003050099
  • [4] Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine
    Aslanian, R
    Mutahi, MW
    Shih, NY
    Piwinski, JJ
    West, R
    Williams, SM
    She, S
    Wu, RL
    Hey, JA
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (12) : 1959 - 1961
  • [5] Identification of a novel, orally bioavailable histamine H3 receptor antagonist based on the 4-benzyl-(1H-imidazol-4-yl) template
    Aslanian, R
    Mutahi, MW
    Shih, NY
    McCormick, KD
    Piwinski, JJ
    Ting, PC
    Albanese, MM
    Berlin, MY
    Zhu, XH
    Wong, SC
    Rosenblum, SB
    Jiang, YH
    West, R
    She, S
    Williams, SM
    Bryant, M
    Hey, JA
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (06) : 937 - 941
  • [6] Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist
    Barbier, AJ
    Berridge, C
    Dugovic, C
    Laposky, AD
    Wilson, SJ
    Boggs, J
    Aluisio, L
    Lord, B
    Mazur, C
    Pudiak, CM
    Langlois, X
    Xiao, W
    Apodaca, R
    Carruthers, NI
    Lovenberg, TW
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (05) : 649 - 661
  • [7] Histamine H3 receptor antagonists reach out for the clinic
    Celanire, S
    Wijtmans, M
    Talaga, P
    Leurs, R
    de Esch, IJP
    [J]. DRUG DISCOVERY TODAY, 2005, 10 (23-24) : 1613 - 1627
  • [8] Non-imidazole heterocyclic histamine H3 receptor antagonists
    Chai, WY
    Breitenbucher, JG
    Kwok, A
    Li, XB
    Wong, V
    Carruthers, NI
    Lovenberg, TW
    Mazur, C
    Wilson, SJ
    Axe, FU
    Jones, TK
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (10) : 1767 - 1770
  • [9] 4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention
    Cowart, M
    Faghih, R
    Curtis, MP
    Gfesser, GA
    Bennani, YL
    Black, LA
    Pan, LP
    Marsh, KC
    Sullivan, JP
    Esbenshade, TA
    Fox, GB
    Hancock, AA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (01) : 38 - 55
  • [10] Medicinal chemistry and biological properties of non-imidazole histamine H3 antagonists
    Cowart, M
    Altenbach, R
    Black, L
    Faghih, R
    Zhao, C
    Hancock, AA
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (09) : 979 - 992